Assessment of Pain During Intramuscular Injection Delay in Adult Psychiatry

Study Overview
=================
Brief Summary
-----------------
Since psychiatry is still too often confronted with a dichotomy between psyche and soma, the assessment of pain and anxiety at RMI is still rarely done (Willer et al., 1982). The objective of this exploratory study is to evaluate the influence of pharmacological factors (type of injected molecules, injection frequency, injection site, treatment duration, treatment dose, time since last injection) and individual about the pain perceived when injecting antipsychotic therapy (diagnosis, sex, age, weight, duration of illness, level of anxiety, psychiatric and somatic comorbidity, insight). In the future, this study will develop a suitable procedure to limit pain and anxiety during RMI. Taking these dimensions into account will probably allow a better compliance of patients for this type of care, and thus a decrease in the number of relapses in the long term.

Official Title
-----------------
Assessment of Pain During Intramuscular Injection Delay in Adult Psychiatry

Conditions
-----------------
Delayed Antipsychotic Treatment, Pharmacological Factors and Individual Factors

Intervention / Treatment
-----------------
* Other: first injection delay and second injection delay


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patients (Males, Females) Over the age of 18 Hospitalized or outpatient Patient affiliated with social security, State Medical Aid (AME) With prescription of antipsychotic delay by intramuscular injection French language mastered Given oral consent to pass the self-assessment scales Exclusion Criteria: Patients on long-term analgesic treatment, daily Patients with chronic pain with or without analgesic treatment Patient not communicating Pregnant woman, parturint and nursing mother Person deprived of liberty by judicial or administrative decision Minor and person subject to legal protection: guardianship or curatorship

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Other
Intervention Model: Single Group Assignment
Interventional Model Description: The group will have a first injection delay and then a second injection delay.
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Other: First injection delay and second injection delay<br>During the first injection, the patient will make 3 scales: END, EVAF and insight and there will be an assessment of induration, redness and swelling done with nurses. During the second injection, the patient will perform the END and EVAF scale and then follow up with a maintenance | Other: first injection delay and second injection delay<br>* During the first injection, the patient will make END scale for 5 seconds, EVAF scale for 10 seconds and insight scale for 5 minutes. The second injection the patient will make END scale for 5 seconds and EVAF scale for 10 seconds and then a maintenance.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| The Digital Scale of Pain (END) |  | 5 seconds | 
| Facial Anxiety Visual Scale (EVAf) |  | 10 seconds | 
| Insight scale |  | 5 minutes | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
pain -injection